EDBT 2026 Demo / reviewers in the wild / expert
Chiara Rapisarda
dblp:425/4319
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2025
—ORCID · unresolved
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 4 heaviest of 4, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › structural bioinformatics
cryo-EM map analysis |
0.9 | 1 | 2025 | Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025 |
Bioinformatics and computational biology
structural bioinformatics |
0.9 | 1 | 2025 | Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025 |
Bioinformatics and computational biology
drug discovery |
0.3 | 1 | 2025 | Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025 |
Bioinformatics and computational biology › protein design
therapeutic antibody design |
0.3 | 1 | 2025 | Finding antibodies in cryo-EM maps with <tt>CrAI</tt> · Bioinform. 2025 |
Methods — techniques the papers use, named apart from their topics
machine learning · 0.9
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2025 | Finding antibodies in cryo-EM maps with <tt>CrAI</tt>abstractMOTIVATION: Therapeutic antibodies have emerged as a prominent class of new drugs due to their high specificity and their ability to bind to several protein targets. Once an initial antibody has been identified, its design and characteristics are refined using structural information, when it is available. Cryo-EM is currently the most effective method to obtain 3D structures. It relies on well-established methods to process raw data into a 3D map, which may, however, be noisy and contain artifacts. To fully interpret these maps the number, position, and structure of antibodies and other proteins present must be determined. Unfortunately, existing automated methods addressing this step have limited accuracy, require additional inputs and high-resolution maps, and exhibit long running times. RESULTS: We propose the first fully automatic and efficient method dedicated to finding antibodies in cryo-EM maps: CrAI. This machine learning approach leverages the conserved structure of antibodies and a dedicated novel database that we built to solve this problem. Running a prediction takes only a few seconds, instead of hours, and requires nothing but the cryo-EM map, seamlessly integrating within automated analysis pipelines. Our method can find the location and pose of both Fabs and VHHs at resolutions up to 10 Å and is significantly more reliable than existing approaches. AVAILABILITY AND IMPLEMENTATION: We make our method available both in open source github.com/Sanofi-Public/crai and as a ChimeraX bundle (crai). Vincent Mallet, Chiara Rapisarda, Hervé Minoux, Maks Ovsjanikov |
Bioinform. | 2 |